Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

05 Days

115 Speakers

Pre-Conference Schedule

Pre-Conference

Tuesday

01

08:00 | 📍Hotel Omni Mont-Royal

PC I: Safety First, Introduction to Pharmacovigilance

Katarina Ilic, ISoP Scientific Board

Francesco Salvo, Université de Bordeaux
Ushma Mehta, Cape Town University
Charles Khouri, CHU Grenoble                                    Tina Bostic, Novavax                                                  Natália Kalousová Kocánková, Primevigilance            John Caminis, Icahn School of Medicine

Parallel Course |📍Hotel Omni Mont-Royal

PC II: RWE in Pharmacovigilance

 

Robert Platt, McGill University

Gianluca Trifiro, Verona University
Luis Pinheiro, EMA
Marco Tuccori, University of Pisa

12:00

Lunch 

13:00 |📍Hotel Omni Mont-Royal

PC III: Approaches for Signal Detection & Assessment from a National and a Global perspective

Monica Tarapués, UMC

Alem Zekarias, UMC
Lisa Wolf, US FDA
Luis Pinheiro, EMA                                                          Taerk Hammad, Takeda

Parallel Course |📍Hotel Omni Mont-Royal

PC IV: Regulatory Framework for Pharmacovigilance

 

Monica Muñoz

Monica Munoz, US FDA

Kelly Robinson, Health Canada
Alison Cave, MHRA
Alex Dodoo, Ghana Standards Authority

17:00

End of day 

Pre-Conference

Wednesday

02

08:00 | 📍Hotel Omni Mont-Royal

PC V: Practical Applications of Evidence-Based Medicine

Tarek Hammad, Takeda

Salman Afsar, BMS

Parallel Course |📍Hotel Omni Mont-Royal

PC VI: Risk Management Plans (RMPs/REMS)

Jean-Christophe Delumeau, IPV

Maribel Salas, Bayer
Yola Moride, YolaRx

12:00

Lunch

13:00 |📍Hotel Omni Mont-Royal

PC VII: Benefit/Risk Assessment from different perspectives

Adel Abou Ali, Takeda

Sara Abdollahi, US FDA                                                    Bennett Levitan, J&J                                                            Ellen Janssen, J&J                                                           Uwe Niehaus, BPI
Tarek Hammad, Takeda

Parallel Course |📍Hotel Omni Mont-Royal

PC VIII: Practical Concepts in Risk Minimization Design and Evaluation

Rania Mouchantaf

Rania Mouchantaf, Health Canada

Jean-Christophe Delumeau, IPV
Yola Moride, YolaRx
Elaine Morrato, Loyola University
Priya Bahri, EMA
Thomas Stammschulte, SwissMedic

17:00

End of the day

Previous Meetings
Stay In Touch